Depletion of <scp>CD</scp>52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting <scp>CD</scp>8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
Immunology